Related Experiment Video
Updated: Mar 21, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Risk of Readmission for Wheezing during Infancy in Children with Congenital Diaphragmatic Hernia
Gregoire Benoist1, Mostafa Mokhtari2, Antoine Deschildre3
1Pneumologie Pédiatrique, Necker, AP-HP, Paris, France, Centre de Référence des Maladies Respiratoires Rares, Paris, France.
Insights
Infants with congenital diaphragmatic hernia (CDH) have frequent respiratory issues and high readmission rates for wheezing. Several factors influence these readmissions, but palivizumab did not reduce them.
Area of Science:
- Pediatric Pulmonology
- Neonatal Surgery
- Clinical Epidemiology
Background:
- Congenital diaphragmatic hernia (CDH) is linked to significant respiratory morbidity post-discharge.
- The frequency of infant re-hospitalization for respiratory issues in CDH patients is not well-established.
Purpose of the Study:
- To determine the readmission rate for wheezing in infants with CDH up to 24 months of age.
- To identify risk factors associated with wheezing-related readmissions in this population.
Main Methods:
- A prospective national database analysis of infants with CDH born in French tertiary centers (2009-2013).
- Inclusion criteria: infants alive at discharge; data extraction for wheezing episodes and readmissions up to 24 months.
- Statistical analysis to identify factors associated with readmission.
Main Results:
- 26% of 86 infants with CDH were readmitted for wheezing exacerbations before 24 months.
- Factors associated with readmission included thoracic liver herniation, low gestational age, prolonged initial hospitalization, home oxygen use, and eczema.
- Respiratory Syncytial Virus (RSV) was detected in 40% of first readmissions with available samples.
- Palivizumab prophylaxis did not correlate with reduced readmission rates or RSV hospitalizations.
Conclusions:
- Infants with CDH experience a high rate of readmission for wheezing exacerbations.
- Prenatal and neonatal factors significantly influence readmission risk.
- Palivizumab prophylaxis showed no impact on reducing wheezing-related readmissions in this cohort.
Rationale:
Congenital diaphragmatic hernia (CDH) is associated with a high incidence of respiratory problems, even after initial hospital discharge. These problems are likely to lead to re-hospitalization during infancy, although actual frequency of readmissions is unknown.
Objective:
We aimed to determine the rate of hospitalization for wheezing in infants with CDH between the time of initial discharge and 24 months of age, and to identify factors associated with readmission.
Methods:
Data about infants with CDH born in three French reference tertiary centers between January 2009 and March 2013 who were alive at hospital discharge, were extracted from a prospective national database.
Results:
Ninety-two children were identified, and 86 were included in the analysis. In total, 116 wheezing episodes requiring a doctor's visit occurred in 50 infants (58%) before 24 months of age. Twenty-two children (26%) were readmitted at least once for wheezing exacerbations. RSV was present in 6 of 15 (40%) of children with available nasal samples at first readmission, and 1 of 5 (20%) at second readmission. Thoracic herniation of the liver, low gestational age, longer initial hospitalization, need for oxygen therapy at home, and eczema were all significantly associated with readmission for wheezing exacerbations. Fifty-three infants (62%) received palivizumab prophylaxis, but there was no association with the overall rate of readmission for wheezing exacerbations or RSV-related hospitalization.
Conclusions:
The rate of readmission for wheezing among infants with CDH is high, and significantly influenced by several prenatal and neonatal factors. Palivizumab prophylaxis was not associated with the rate of readmission.
Related Concept Videos
Pulmonary Cycle: Exhalation
Pneumothorax-II
Clinical Manifestations:
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Acute Respiratory Failure-III

